Abstract:Introduction T-614 is a novel oral antirheumatic agent for the treatment of rheumatoid arthritis. Whether it has immunomodulatory or disease-modifying properties and its mechanism of action are largely undetermined. Methods Rats with collagen-induced arthritis (CIA) were treated with T-614 (5 and 20 mg/kg) daily. Animals receiving methotrexate (1 mg/kg every 3 days) and the nonsteroidal anti-inflammatory agent nimesulide (10 mg/kg per day) were used as controls. A combination therapy group was treated with both T-614(10 mg/kg per day) and methotrexate (1 mg/kg every 3 days). Hind paw swelling was evaluated and radiographic scores calculated. Serum cytokine levels were assessed by Bio-plex analysis. Quantitative PCR was used to evaluate expression of mRNA for interferon-γ, IL-4 and IL-17. Serum IL-17 and anti-type II collagen antibodies (total IgG, IgG 1 , IgG 2a , IgG 2b and IgM) were measured using ELISA. Results Oral T-614 inhibited paw swelling and offered significant protection against arthritis-induced cartilage and bone erosion, comparable to the effects of methotrexate. CIA rats treated with T-614 exhibited decreases in both mRNA expression of IL-17 in peripheral blood mononuclear cells and lymph node cells, and circulating IL-17 in a dose-dependent manner. T-614 also reduced serum levels of tumor necrosis factor-α, IL-1β and IL-6. A synergistic effect was observed for the combination of methotrexate and T-614. In addition, T-614 (20 mg/kg per day) depressed production of anti-type II collagen antibodies and differentially affected levels of IgG 2a subclasses in vivo , whereas IgM level was decreased without any change in the IgG 1 level. Together, the findings presented here indicate that the novel agent T-614 has disease-modifying effects against experimental arthritis, as opposed to nimesulide. Conclusions Our data suggested that T-614 is an effective disease-modifying agent that can prevent bone/cartilage destruction and inflammation in in CIA rats. Combination with methotrexate markedly enhances the therapeutic effect of T-614.

Effects Of A Novel Tylophorine Analog On Collagen-Induced Arthritis Through Inhibition Of The Innate Immune Response

Therapeutic effects of a novel tylophorine analog, NK-007, on collagen-induced arthritis through suppressing tumor necrosis factor α production and Th17 cell differentiation.

T-614, a novel immunomodulator, attenuates joint inflammation and articular damage in collagen-induced arthritis

A Novel BLyS Peptibody Down-Regulates B Cell and T Helper Cell Subsets in Vivo and Ameliorates Collagen-Induced Arthritis.

Theaflavin-3,3?-Digallate Ameliorates Collagen-Induced Arthritis Through Regulation of Autophagy and Macrophage Polarization

Therapeutic Effect of Cryptotanshinone on Collagen-Induced Arthritis in Rats Via Inhibiting Nuclear Factor Kappa B Signaling Pathway

Co-Expression of Il-18 Binding Protein and Il-4 Regulates Th1/Th2 Cytokine Response in Murine Collagen-Induced Arthritis

Therapeutic effects of TACI-Ig on collagen-induced arthritis by regulating T and B lymphocytes function in DBA/1 mice.

L161982 alleviates collagen-induced arthritis in mice by increasing Treg cells and down-regulating Interleukin-17 and monocyte-chemoattractant protein-1 levels

A Betulinic Acid Derivative Sh479 Inhibits Collagen-Induced Arthritis by Modulating T Cell Differentiation and Cytokine Balance

A Novel Fusion Protein Attenuates Collagen-Induced Arthritis by Targeting Interleukin 17A and Tumor Necrosis Factor Alpha

The Therapeutic Effects of Daphnetin in Collagen-Induced Arthritis Involve Its Regulation of Th17 Cells

Therapeutic Effect of Emodin on Collagen-Induced Arthritis in Mice

Synthesis of Novel Tylophorine Derivatives and Evaluation of Their Anti-Inflammatory Activity.

Regulatory effect of daphnetin, a coumarin extracted from Daphne odora, on the balance of Treg and Th17 in collagen-induced arthritis.

Treatment of Collagen-Induced Arthritis with an Anti-Osteopontin Monoclonal Antibody Through Promotion of Apoptosis of Both Murine and Human Activated T Cells

[Cheng's Juanbi Decoction alleviates the inflammation in collagen-induced arthritis (CIA) rats via inhibiting activation of PI3K/AKT/mTOR pathway].

A Selective CB2 Agonist Protects Against the Inflammatory Response and Joint Destruction in Collagen-Induced Arthritis Mice.

The experimental study on the effect of rhTNFR:Fc and methtotrexate-rhTNFR:Fc on joint destruction of collagen-induced arthritis rat

Blocking the Sphingosine-1-Phosphate Receptor 2 (S1P2) Reduces the Severity of Collagen-Induced Arthritis in DBA-1J Mice

Effects of regulation of Gal-9/Tim-3 pathway on murine collagen-in-duced arthritis